As the cornerstone and flagship service of Chongqing Haifu Hospital, High-Intensity Focused Ultrasound (HIFU) non-invasive ablation represents an original and globally advanced medical technology. Unlike traditional surgical approaches, HIFU offers a revolutionary method for treating both benign and malignant solid tumors without making a single incision.

The core mechanism of HIFU therapy relies on precise, real-time ultrasonic positioning. By focusing high-intensity ultrasound waves on a specific target lesion, the technology generates instantaneous high temperatures—ranging from 65°C to 100°C—at the focal point. This process induces complete thermal coagulation necrosis of the pathological tissue while leaving surrounding healthy structures unharmed.

From a clinical perspective, HIFU offers a painless, radiation-free, and bloodless alternative to conventional surgery. It eliminates the need for surgical blades, anesthesia-related risks of open surgery, and most critically, avoids organ resection. This organ-preserving capability ensures that the anatomical integrity and physiological functions of the affected organ remain intact post-treatment, offering significant advantages for patients of reproductive age or those refusing surgical removal.

Clinical Applications:

Chongqing Haifu Hospital has established a standardized HIFU treatment system applicable to a wide spectrum of diseases, specifically categorized into:

1. Gynecological Benign Conditions: The hospital is globally recognized for treating uterine fibroids and adenomyosis, providing relief from heavy bleeding and severe dysmenorrhea while protecting fertility. It is also highly effective for cesarean scar pregnancy.
2. Breast and Hepatic Oncology: The treatment is widely used for breast benign tumors as well as primary and metastatic liver cancer.
3. Pancreatic and Musculoskeletal Malignancies: HIFU demonstrates remarkable outcomes for pancreatic cancer (often deemed inoperable) and provides a limb-salvage option for bone tumors and soft tissue tumors.
4. Other Solid Malignancies: The technology addresses various solid malignant tumors.
5. Palliative Oncology: For late-stage cancer patients, HIFU serves as an effective palliative treatment to debulk tumors, relieve severe cancer pain, reduce tumor burden, and significantly improve overall quality of life.

In summary, through real-time imaging guidance and precise thermal ablation, HIFU offered at Chongqing Haifu Hospital is redefining the standard of care for minimally invasive and non-invasive therapy, effectively bridging the gap between radical treatment and enhanced patient recovery.